NEW YORK, Feb. 28, 2026 -- From February 26 to 27, the NPIAP 2026 Annual Conference was held in the United States, bringing together leading clinicians, researchers, and healthcare professionals to advance the prevention and management of pressure injuries. Dimora Medical, a continuous innovator in high-end medical care supplies, participated as the exclusive sponsor of the conference opening ceremony, joining the organizer in spotlighting pressure injury prevention, clinical best practices, and long-term support for affected patients and caregivers. The conference was organize
NEW YORK, Feb. 28, 2026 -- Since the launch of BestQool, this company has always aimed to deliver the most for its customers and continuously improve its home-use products, focusing on red light therapy devices. BestQool's executives carefully summarized feedback on the BQ60 and developed an improved version, the BQ60Pro. "BQ60's strong market performance proved the maturity and reliability of its core design framework," says Jacob, CEO of BestQool. "The BQ60Pro not only builds on that foundation with broader spectral distribution but, crucially, also gives our c
Patent leadership reinforces company's leading position in the global CBCT market HWASEONG, South Korea, Feb. 27, 2026 -- Vatech (KOSDAQ: 043150), a global manufacturer of dental imaging systems, announced that cumulative patent data over the past 20 years demonstrate its technological leadership in dental diagnostic imaging. Under the internationally recognized IPC classification A61B (medical diagnostics), Vatech ranked first in cumulative patent applications and granted patents among leading global dental diagnostic equipment manufacturers over the 2005–
SHANGHAI, Feb. 27, 2026 -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, today announced a strategic collaboration with Earendil Labs on WuXi XDC's proprietary WuXiTecan-2 payload-linker technology platform. Earendil Labs is an AI-powered biotech company focused on researching and developing next-generation innovative biologics for the treatment of autoimmune diseases, cancer, and other conditions with unmet medica
WILMINGTON, Del., Feb. 27, 2026 -- Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, today announced a strategic collaboration with WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK) on WuXi XDC's proprietary WuXiTecan-2 payload-linker technology platform. WuXi XDC Cayman Inc. (stock code: 2268.HK) is a globally recognized contract research, development, and manufacturing organization (CRDMO) specializing in bioconjugates. The company offers a wide range of innovative conjugation and payload-linker technologies to fac
SEOUL, South Korea, Feb. 27, 2026 -- Medit, a global provider of digital dentistry solutions, today announced that the "Glow Together" campaign will begin this March. The 'Glow Together' initiative began with small steps taken by the female employees of Medit. Light becomes more powerful when it is shared. Created in the spirit of International Women's Day, Glow Together is designed to spark connection across the dental community—and to translate participation into meaningful, real-world care beyond the clinic. While inspired by International Women's Day and t
SINGAPORE, Feb. 27, 2026 -- The ASEAN Foundation organized the regional programme "CALM MRI – Fear to Confidence: Learning through Play with LEGO MRI Kits Programme", implemented across Indonesia and Singapore. The initiative serves as a platform to present the programme's outcomes, which aim to help children better understand Magnetic Resonance Imaging (MRI) procedures through a play-based learning approach. Designed to reduce anxiety and build familiarity, CALM MRI introduces children to the MRI process using specially designed LEGO® MRI kits. By transforming a
SUZHOU, China, Feb. 27, 2026 -- Basecare Medical (02170.HK) has recently encountered a key catalyst——its Gems one-step embryo culture medium has officially obtained the China Class III Medical Device Registration Certificate (National Medical Products Administration Registration No. 20253180071). This represents a core signal of the company's strategic transformation implementation and accelerated domestic substitution layout, and is expected to become an important driver for its valuation repair, warranting close attention. From a market logic perspective, the approval of this product
SINGAPORE, Feb. 27, 2026 -- Cynosure Lutronic, a global leader in energy-based medical aesthetic devices, announced today that Clarity II, its dual-wavelength long-pulse laser platform, has received regulatory approval in China and Japan. This marks a significant expansion of the company's clinically approved laser portfolio across two of Asia's most highly regulated aesthetic markets. "The approval enables the introduction of a single, integrated dual wavelength laser platform designed to support multiple treatment indications and diverse patient profiles and is
[ 메디채널 김갑성 기자 ] TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data demonstrates its accuracy in detecting rare genetic diseases 40% increase in output to 35 billion reads, up to Q70 quality scores, improved turnaround time, and staggered starts are among the updates to be rolled out on all NovaSeq X systems, advancing precision medicine and delivering compounded value for NovaSeq X customers At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions SAN DIEGO, Feb. 27, 2026 -